2 recruiting, 1 completed. .
Follow Prolaio: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of the Progression of Chronic Cardiovascular Conditions Cardiovascular Disease (CVD), Heart Failure | Recruiting | Prolaio | 5000 | 2025-10-30 | 2026-08-12 | |
| A Noninterventional, Single-Center Feasibility Study to Evaluate Measures of Heart Failure Risk Software - Heart Failure, Cardiomyopathy, Hypertrophic | Completed | Prolaio | 82 | 2022-10-28 | 2024-10-24 | |
| Observational, Non-Interventional Study Supporting Validation of eVO2peak Using Results in Patients Receiving Standard of Care Cardiopulmonary Exercise Tests (CPET) Cardiopulmonary | Recruiting | Prolaio | 2000 | 2019-06-06 | 2026-09-09 |
Cardiomyopathy, Hypertrophic (2) · Heart Failure (2) · Aortic Valve Stenosis (1) · Cardiomyopathy, Dilated (1) · Cardiovascular Diseases (1) · Hypertension (1) · Hypertrophy, Left Ventricular (1) · familial dilated cardiomyopathy (1)
United States (3) · Canada (1)
Greg Kurio, MD (1) · Michael Koren, MD (1)